BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2405549)

  • 1. Cyclosporine-induced hypertension in sheep. The role of thromboxanes.
    Tresham JJ; Whitworth JA; Scoggins BA; Bennett WM
    Transplantation; 1990 Jan; 49(1):144-8. PubMed ID: 2405549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The protective effect of thromboxane synthetase inhibition on renal function in systemic sepsis.
    Cumming AD; McDonald JW; Lindsay RM; Solez K; Linton AL
    Am J Kidney Dis; 1989 Feb; 13(2):114-9. PubMed ID: 2916566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of experimental cyclosporine nephrotoxicity by inhibition of thromboxane synthesis.
    Petric R; Freeman D; Wallace C; McDonald J; Stiller C; Keown P
    Transplantation; 1990 Oct; 50(4):558-63. PubMed ID: 2219273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of glomerular filtration rate by the thromboxane receptor antagonist L655,240 during low dose cyclosporine administration.
    Bunke M; Wilder L; Martin A
    Prostaglandins; 1992 Apr; 43(4):351-60. PubMed ID: 1535164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporin A-induced nephrotoxicity in the rat: relationship to increased plasma renin activity.
    McAuley FT; Simpson JG; Thomson AW; Whiting PH
    Agents Actions; 1987 Jun; 21(1-2):209-16. PubMed ID: 3307341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of chronic cyclosporine administration on renal blood flow and intrarenal blood flow distribution.
    Youngelman DF; Kahng KU; Rosen BD; Dresner LS; Wait RB
    Transplantation; 1991 Feb; 51(2):503-9. PubMed ID: 1994546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of cyclosporine A (CSA) on intrarenal control of GFR.
    Duggin GG; Baxter C; Hall BM; Horvath JS; Tiller DJ
    Clin Nephrol; 1986; 25 Suppl 1():S43-5. PubMed ID: 3708936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The failure of nisoldipine to prevent the hypertensive response to cyclosporine A infusion in sheep.
    Tresham JA; Whitworth JA; Scoggins BA; Bennett WM
    J Hypertens; 1990 Nov; 8(11):1007-13. PubMed ID: 1963182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that renal prostaglandin and thromboxane production is stimulated in chronic cyclosporine nephrotoxicity.
    Coffman TM; Carr DR; Yarger WE; Klotman PE
    Transplantation; 1987 Feb; 43(2):282-5. PubMed ID: 3810836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase in urinary thromboxane B2 in rats caused by cyclosporine.
    Kawaguchi A; Goldman MH; Shapiro R; Foegh ML; Ramwell PW; Lower RR
    Transplantation; 1985 Aug; 40(2):214-6. PubMed ID: 4024243
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of thromboxane synthetase inhibition and angiotensin converting enzyme inhibition on acute cyclosporin A nephrotoxicity.
    Grieve EM; Hawksworth GM; Simpson JG; Whiting PH
    Biochem Pharmacol; 1990 Nov; 40(10):2323-9. PubMed ID: 2244933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effects of U-63,557A, a thromboxane synthetase inhibitor, in an ovine model of pregnancy-induced hypertension.
    Keith JC; Thatcher CD; Schaub RG
    Am J Obstet Gynecol; 1987 Jul; 157(1):199-203. PubMed ID: 3605254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of thromboxane synthesis attenuates insulin hypertension in rats.
    Keen HL; Brands MW; Smith MJ; Shek EW; Hall JE
    Am J Hypertens; 1997 Oct; 10(10 Pt 1):1125-31. PubMed ID: 9370383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute cyclosporine A nephrotoxicity in rats: which role for renin-angiotensin system and glomerular prostaglandins?
    Perico N; Benigni A; Bosco E; Rossini M; Orisio S; Ghilardi F; Piccinelli A; Remuzzi G
    Clin Nephrol; 1986; 25 Suppl 1():S83-8. PubMed ID: 3519031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Functional renal effects of cyclosporin. Physiopathological mechanisms].
    Deray G; Martinez F; Cacoub P; Baumelou A; Jacobs C
    Nephrologie; 1988; 9(2):73-5. PubMed ID: 3050579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporine-induced renal dysfunction in human renal allograft recipients.
    Kiberd BA
    Transplantation; 1989 Dec; 48(6):965-9. PubMed ID: 2688208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of endothelin ET(A), but not thromboxane, receptors offsets the cyclosporine-evoked hypertension and interrelated baroreflex and vascular dysfunctions.
    Nasser SA; Elmallah AI; Sabra R; Khedr MM; El-Din MM; El-Mas MM
    Eur J Pharmacol; 2014 Mar; 727():52-9. PubMed ID: 24486390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thromboxane and prostacyclin in acute lung injury caused by venous air emboli in unanesthetized sheep.
    Bonsignore MR; Rice TR; Dodek PM; Staub NC
    Microcirc Endothelium Lymphatics; 1986; 3(2):187-212. PubMed ID: 3295507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephrotoxicity of cyclosporine in spontaneously hypertensive rats: effects on blood pressure and vascular lesions.
    Ryffel B; Siegl H; Petric R; Muller AM; Hauser R; Mihatsch MJ
    Clin Nephrol; 1986; 25 Suppl 1():S193-8. PubMed ID: 3519026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporine dose adjustment using levels obtained six hours after the morning dose: effect on side effects in patients with autoimmune diseases.
    Cantarovich M; DeschĂȘnes J
    Am J Nephrol; 1997; 17(5):450-7. PubMed ID: 9382165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.